2.05
Microbot Medical Inc Aktie (MBOT) Neueste Nachrichten
Is Microbot Medical Inc. (MBOT) the Best Rising Penny Stock to Buy According to Analysts? - Insider Monkey
Microbot Medical announces proxy statement for annual meeting By Investing.com - Investing.com South Africa
Microbot Medical announces proxy statement for annual meeting - Investing.com
Microbot Medical modifies shareholder meeting quorum By Investing.com - Investing.com Canada
Microbot’s Liberty Boosts Stock: What’s Next? - timothysykes.com
Microbot Medical modifies shareholder meeting quorum - Investing.com
Microbot Medical's (MBOT) Robotic System Achieves Key Trial Succ - GuruFocus
H.C. Wainwright maintains $9 target on Microbot Medical stock By Investing.com - Investing.com South Africa
Microbot Medical (MBOT) Awaits FDA Decision on LIBERTY® Robot - GuruFocus
Microbot posts pivotal surgical robot data; GE Healthcare hires Patient Care Solutions leader - Yahoo Finance
H.C. Wainwright maintains $9 target on Microbot Medical stock - Investing.com
Microbot Medical reports successful robotic trial By Investing.com - Investing.com Canada
Microbot Medical® Shares Results from Its Pivotal Clinical Trial - GuruFocus
Microbot Medical Data Backs Liberty Endovascular Surgical Robot - Medical Product Outsourcing
Sector Update: Health Care Stocks Rise Wednesday Afternoon - TradingView
Sector Update: Health Care - marketscreener.com
Microbot Medical (MBOT) Appoints Paul Mullen as VP of Sales - GuruFocus
Microbot Medical (MBOT) Advances Telesurgery with LIBERTY® Syste - GuruFocus
Microbot Medical (MBOT) Unveils Promising Trial Data for LIBERTY System - GuruFocus
Microbot Medical (MBOT) Secures $13 Million Through Direct Offering - GuruFocus
Microbot Medical shares results from ACCESS-PVI pivotal trial - Vascular News
Microbot Medical Feels a Strong Surge Again? - timothysykes.com
Microbot Medical (MBOT) Surges on Successful Trial Results - GuruFocus
Microbot Medical Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the Liberty® Endovascular Robotic System - MarketScreener
Microbot Medical reports successful robotic trial - Investing.com
Microbot Medical Says Study Shows Endovascular Robotic System Feasible - MarketScreener
Microbot Medical Stock Soars: Is the Rally Sustainable? - timothysykes.com
Microbot Medical Presents Successful Trial Results for LIBERTY System - TipRanks
Microbot Medical stock rises on trial win (MBOT:NASDAQ) - Seeking Alpha
Microbot Medical® Shares Results From Its Pivotal Clinical Trial - MarketScreener
Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic ... - Bluefield Daily Telegraph
Microbot Medical® Shares Results from Its Pivotal Clinical - GlobeNewswire
Groundbreaking Clinical Trial: New Robotic System Cuts Surgeon Radiation by 92% - Stock Titan
Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System - The Manila Times
Microbot Medical (NASDAQ:MBOT) Shares Pass Above Two Hundred Day Moving Average – Here’s Why - Defense World
Microbot Medical to Present ACCESS-PVI Trial Data - TipRanks
REMINDER: Microbot Medical Announces Data from the - GlobeNewswire
Groundbreaking Clinical Trial Results: Revolutionary Endovascular Robot Faces Critical FDA Decision - Stock Titan
Microbot Medical Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Paul Mullen Chosen to Lead Microbot Medical’s U.S. Sales Force - Medical Product Outsourcing
MICROBOT MEDICAL Earnings Preview: Recent $MBOT Insider Trading, Hedge Fund Activity, and More - Nasdaq
Microbot Medical Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
Microbot Medical (MBOT) to Release Quarterly Earnings on Wednesday - Defense World
Microbot Medical (NASDAQ:MBOT) Stock Passes Above 200 Day Moving Average – What’s Next? - Defense World
Microbot Medical Stock Price, Quotes and Forecasts | NASDAQ:MBOT - Benzinga
Microbot Medical names Paul Mullen as VP, sales - Medical Buyer
Microbot Medical Appoints Seasoned Endovascular Sales - GlobeNewswire
Microbot Medical Appoints New VP Ahead of Product Launch - TipRanks
Microbot Medical appoints Paul Mullen as VP, sales - TipRanks
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):